From Crisis to Opportunity: COVID-19 Disruption in Life Sciences Supply Chains

In today's digital age, paper and manual-human intensive processes are still the backbones powering most Life Sciences supply chains. But with the Supply Chain as a critical element of business, the time is now to plan for the next new normal and turn Supply Chains into an engine for growth and innovation. The immediate focus needs to be on improving visibility and transparency to supply chain risk —in direct suppliers, providers, facilities and beyond.

Important components like AI/ML, automation, data lake platforms and other emerging technologies will shape the future pharma supply chains, not only to survive but to gain competitive advantage. 

And by enabling these building blocks, the future supply chain transforms from linear to dynamic as seen below.

 

Explore this perspective below by Stephanie David to learn more about:

Download the PDF

Learn More

How to Foster Resiliency in a Time of Crisis
Perspective
by Marc Helberg
3 Ways to Get High-Tech Devices to the Market Quickly and Safely
Uncovering Dark Data
Perspective
by Marc Helberg
Disrupt or Be Disrupted: What Executives Need to Know About the Future of Healthcare
COVID-19 Hospital Response
Perspective
by Marc Helberg
3 Ways Organizations Can Embrace the Future of Population Health
Learn More